Cargando…
Severe Toxicity with a Generic Formulation of Zoledronic Acid: A Case Report
Intravenous zoledronic acid (ZOL) is an integral component for the management of patients with bone metastases, but can be associated with transient flu-like symptoms, which generally occur only with the first infusion and are typically manageable with nonprescription analgesics. A 50-year-old woman...
Autor principal: | Sanchez, Benito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480876/ https://www.ncbi.nlm.nih.gov/pubmed/23115481 http://dx.doi.org/10.4137/CCRep.S8825 |
Ejemplares similares
-
Docetaxel/zoledronic acid: Multisystem toxicities: case report
Publicado: (2020) -
Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report
por: Noriega Aldave, Adrian P, et al.
Publicado: (2014) -
Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
por: Al Elq, Abdulmohsen H.
Publicado: (2013) -
Denosumab/ibandronic acid/zoledronic acid: Medication-related osteonecrosis of jaw: case report
Publicado: (2021) -
Acute unilateral anterior uveitis following zoledronic acid infusion: A case report
por: Anandasayanan, Kiruththihan, et al.
Publicado: (2020)